Targeted-delivery of chemotherapy (NANOLEUK) vs standard chemotherapy in acute myeloid leukemia: a proposed randomized, double-blinded, multicenter efficacy trial. PPCR [Internet]. 2016 Nov. 8 [cited 2024 Nov. 23];2(2). Available from: https://journal.ppcr.org/index.php/ppcrjournal/article/view/44